| Ytd | -76.26% | |
| 1y | -82.90% |
| Open | 1.83 | Prev Close | 1.81 | Low | 1.78 | High | 1.92 | Mkt Cap | 49.67M |
| Vol | 306.20K | Avg Vol | 340.72K | EPS | -2.16 | P/E | N/A | Forward P/E | -1.96 |
| Beta | 1.32 | Short Ratio | 2.49 | Inst. Own | 5.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.48 | 200-d Avg | 7.28 | 1yr Est | 9.50 |
ELTX News
B. Riley Securities analyst Mayank Mamtani maintains Elicio Therapeutics (NASDAQ:ELTX) with a Buy
HC Wainwright & Co. analyst Robert Burns reiterates Elicio Therapeutics (NASDAQ:ELTX) with a
Elicio Therapeutics (NASDAQ:ELTX) reported quarterly losses of $(0.43) per share which beat the anal
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 95.7% to $1.4 during Wednesday's
Gainers Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's
Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 40.9% to $0.16 during Thursday's pre-
Smith & Wesson (SWBI) shares rose in pre-market trading after posting strong Q4 results, beating
US stocks gain on peace agreement with Iran, Nasdaq up 2%, Dow up 1.1%, S&P 500 up 1.54%. Tech s
US stocks rise on peace agreement with Iran, Dow up 600 points. Tech sector jumps, energy stocks dow
